INCOG BioPharma Services plans a $200 million expansion in Fishers, creating nearly 1,000 jobs and boosting Indiana's drug ...

UK energy secretary Ed Miliband has backed Copenhagen Infrastructure Partners (CIP) in a radar row with BAE Systems over a demand that could have seen a newly consented offshore wind farm shut down ...

AstraZeneca offers a rare, secular growth profile in biopharma, underpinned by a diversified commercial asset base and layered patent expirations. AZN faces a minor patent cliff, with most key ...

Uncertainty reigned early this year with the inauguration of President Donald Trump and his threats to impose tariffs and slash prescription drug prices. But as players in the biopharma industry have ...

Even with Johnson & Johnson’s (J&J) $14.6bn buyout of Intra-Cellular Therapies in January setting a strong deal-making tone, 2025 still delivered a few surprises. A bidding war between Pfizer and Novo ...

At the BIO-Europe congress in Vienna, the session titled “From Roasts to Billions: Biopharma Investment Landscape” brought together leading voices from investment banking and venture capital to ...

As 2025 closes, biopharma and healthcare are learning to live on shifting ground. | Fierce reporters break down the forces that shaped biopharma and healthcare in 2025 and what lies ahead in 2026.

LOS ANGELES, CA, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), a global leader in relapsed/refractory AL Amyloidosis, today announced ...

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced an expansion of its bioprocessing capabilities across Asia, reinforcing its ...

Arlington County Manager Mark Schwartz presented his proposed FY 2025–2034 Capital Improvement Plan (CIP) to the Arlington County Board on Tuesday, May 28, 2024. The proposal outlines $4.5 billion in ...

Vor Biopharma Inc. offers a high-risk, high-reward play on U.S. commercialization of telitacicept, a dual-target autoimmune drug approved in China. Complex warrant issuances and reverse stock split ...

BofA made several estimate and target changes across the firm’s broader Biopharma Services names, upgrading Charles River (CRL), Mettler-Toledo (MTD) and Schrodinger (SDGR) all to Buy from Neutral and ...